Related Experiment Videos
[Prevention with angiotensin-converting enzyme (ACE) inhibitors]
G Ertl1, P Gaudron, S Neubauer
1Medizinische Klinik, Universität Würzburg.
Zeitschrift Fur Kardiologie
|January 1, 1992
Summary
Angiotensin-converting-enzyme (ACE) inhibitors show promise in preventing heart failure after myocardial infarction. Studies indicate they can reduce heart failure incidence by one-third in patients with severe left ventricular dysfunction.
Area of Science:
- Cardiology
- Pharmacology
Context:
- Angiotensin-converting-enzyme (ACE) inhibitors are established treatments for hypertension and chronic heart failure.
- Their mechanism involves inhibiting angiotensin-II production, leading to vasodilation and reduced cardiac workload.
- Local renin-angiotensin systems in cardiac and vascular cells represent another potential site of action.
Purpose:
- To evaluate the role of ACE inhibitors in preventing cardiovascular complications, particularly heart failure, in patients with left ventricular dysfunction.
- To explore the potential new indication for ACE inhibitors in post-myocardial infarction left ventricular dysfunction.
Summary:
- Recent studies, including SOLVD and SAVE, demonstrated that ACE inhibitors can prevent heart failure in approximately one-third of patients with severe left ventricular dysfunction over three years compared to placebo.
- This suggests a significant benefit in managing post-myocardial infarction complications.
Impact:
- ACE inhibitors may become a key preventive therapy for left ventricular dysfunction following myocardial infarction.
- Further research is needed to determine optimal diagnostic procedures, treatment timing, duration, dosage, potential side effects, and the specificity of this preventive effect.